Wednesday, August 07, 2024 8:40:59 AM
Let Nasrat Hakim run the show - buy some popcorn and watch your investment grow!!!
Right, just like I've been watching it grow for the past 8 years. My investment has finally grown back to it's 2016 level. Hakim's show has been marked by monumental failures of his own making and only moderate successes that required a lot of help. Throughout his entire tenure he has ignored his fiduciary duty to Elite shareholders and repeatedly favored himself in a series of unfair self-deals with Mikah. He charged us $10,000,000 for a rag tag collection of ANDA's that weren't worth half a million dollars on their best day. To hide the malfeasance, he then parked those ANDA's with his BUSINESS PARTNERS at Epic and proceeded to blame THEM for doing nothing. He lied to shareholders and the whole world in a press release that claimed SequestOx was bio-equivalent with comparator, when he very well knew it was very far from bio-equivalent under fed conditions. It was a billion dollar lie, and shareholders had to be told about it by the FDA in a CRL. He hyped the 3 buckets incessantly, and then he sold off the generic opioids nearly as soon as they were approved. He starved the company of revenue, and then claimed to be the savior by overcharging us 100X for toxic trimipramine, which Mikah acquired long after Hakim told shareholders and the SEC that Mikah had wound down operations. When Elite had the opportunity to acquire full ownership of the their flagship Adderall ANDAs, Hakim couldn't be bothered to arrange a deal on behalf of shareholders. Instead, he made the deal for himself, and it has been a very lucrative deal for Mikah and Hakim personally. But the Adderall profit splits are only a drop in the bucket compared to what he intends to get for these ANDA's. When it finally comes time for a buyout, he will make a secret side deal for these properties that will make him fabulously wealthy. Whatever slimy second tier company is willing to deal with him, they will gladly make an overly generous secret deal for Mikah in exchange for a massive discount for public Elite. Hakim gets the gold saying "None of your business" while shareholders sit and wonder what happened to our payout.
I will never understand why shareholders show such incredible deference to a self-interested mediocre CEO like Hakim, but I for one think he's gotten rich enough off the backs of Elite shareholders. It's time for him to do the right thing and extract Mikah entirely from Elite. We need a neutral mediator to simulate an arm's length transaction, and we need to buy out Mikah immediately. Whatever the cost, today is the cheapest it will ever be. Tomorrow it gets more expensive and every day thereafter it gets harder and costs more to do. If we continue to kick the can down the road until the buyout, then Hakim will get his secret side deal for Mikah, and Elite shareholders will get screwed yet again. Fiduciary duty be damned. This is the Mikah Tax we will all pay at buyout if we don't force Mikah out now. All one has to do is look at Hakim's history with Mikah and Elite shareholders, and it becomes obvious what his intentions are for Mikah and Adderall.
Stop making excuses for a man who has screwed you over multiple times. Flick the tick, repeal the Mikah Tax now.
.
Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 11:05:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 11:05:36 AM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
